The abstracts accepted for mini oral presentations include updated efficacy and safety data from the Phase 2b REZILIENT1 ...

The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in Duchenne patients who can still walk, however.

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement ...

United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...

Health and Human Services Secretary Robert F. Kennedy Jr. last month told a congressional panel that the administration was ...

Against that backdrop, United Therapeutics is facing specific questions about near-term sales performance, particularly ...

United Therapeutics (UTHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside ...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of ...

The Clovis Police Department will conduct a DUI checkpoint on Friday from 8 p.m. to 1 a.m. at an undisclosed location, ...

The United States has rejected amendments adopted in 2024 by members of the World Health Organization to its legally binding ...